ACCD:NSD-Accolade Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 8.20

Change

+0.31 (+3.93)%

Market Cap

USD 0.61B

Volume

0.72M

Avg Analyst Target

USD 12.91 (+57.39%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

ACCD Stock Forecast & Price:
Based on the Accolade Inc stock forecasts from 11 analysts, the average analyst target price for Accolade Inc is USD 12.91 over the next 12 months. Accolade Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Accolade Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Accolade Inc’s stock price was USD 8.20. Accolade Inc’s stock price has changed by +0.12% over the past week, -25.52% over the past month and -69.15% over the last year.

About Accolade Inc (ACCD:NSD)

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technol ...Read More

Company Website : https://www.accolade.com

Address : 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

Employees : 2,350

Fiscal Year End : February

Currency: USD

Country : USA

Technical Indicators

Beta : 1.48

52 Week High : 27.74

Short Ratio : 7.37

52 Week Low : 4.61

Shorted Shares : 4,324,166

200 Day Moving Average : 11.19

Shorted Shares Previous Month : 4,192,870

50 Day Moving Average : 10.68

Shares Held By Insiders : 4.12%

Short Percentage : 6.12%

Shares Held by Institutions : 78.57%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-11-29 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CHNG Change Healthcare Inc

N/A

 USD9.03B N/A 16.98
INOV Inovalon Holdings Inc

N/A

 USD6.37B 122.57 33.93
HQY HealthEquity Inc

+0.33 (+0.53%)

 USD5.28B 789.30 54.37
TXG 10X Genomics Inc

+0.27 (+0.78%)

 USD3.96B N/A -29.54
PINC Premier Inc

+0.32 (+0.97%)

 USD3.90B 20.81 11.07
ONEM 1Life Healthcare Inc

+0.10 (+0.60%)

 USD3.44B N/A -12.12
HMSY HMS Holdings Corp

N/A

 USD3.29B 47.40 23.59
PGNY Progyny Inc

-0.32 (-0.87%)

 USD3.19B 79.95 143.23
RCM R1 RCM Inc

+0.74 (+9.85%)

 USD3.18B 69.45 26.98
PRVA Privia Health Group Inc

-0.41 (-1.81%)

 USD2.62B N/A -64.01

ETFs Containing ACCD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -68.89% 47% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -68.89% 47% F 22% F
Trailing 12 Months  
Capital Gain -68.06% 50% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -68.06% 50% F 25% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -30.90% 8% F 8% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.90% 8% F 8% F
Risk Return Profile  
Volatility (Standard Deviation) 36.07% 52% F 44% F
Risk Adjusted Return -85.66% 12% F 7% F
Market Capitalization 0.61B 63% D 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio -99,999.99 100% A+ 100% A+
Price/Book Ratio 1.20 60% D- 67% D+
Price / Cash Flow Ratio -9.74 73% C 71% C-
EV/EBITDA -1.71 63% D 64% D
Management Effectiveness  
Return on Equity -64.75% 24% F 24% F
Return on Invested Capital -15.72% 46% F 38% F
Return on Assets -9.69% 51% F 36% F
Debt to Equity Ratio 32.80% 42% F 47% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 7.37 31% F 17% F
Short Percent 6.12% 30% F 25% F
Beta 1.48 34% F 23% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

New Post

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment
Stock Target Advisor

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.